傳奇生物 LEGN 深滬

交易中 01-27 10:51:55 美东时间

18.56

-0.400

-2.11%

華盛通

立即下載

最高19.28
今開18.83
成交量 49.18万股
最低 18.54
昨收 18.96
總市值 34.15亿
52周最高 45.2972
市盈率 ^靜 --
換手率 0.27%
52周最低 18.54
委比 -96.03%
總股本 1.84亿
歷史最高 77.32
量比 0.61
振幅 3.90%
歷史最低 18.54
每手 1
風險率 5.22%

個股概要

財務分析

公司資料

分紅派息

分時圖
日k
周k
月k

相關新聞

美股大行评级 | 潜在涨幅258.31%！Tempest Therapeutics获HC Wainwright上调评级至"买入"，目标价11美元

今日重点评级关注：HC Wainwright & Co.：上调Tempest Therapeutics评级至"买入"，目标价11美元；Guggenheim：维持Sportradar Gr"买入"评级，目标价从34美元升至35美元

01-23 19:46
【美股收市】美股三大指数悉数收涨纳指涨0.91%

金吾资讯

01-23 08:39
百万抗癌药海外大卖，传奇生物CAR-T去年销售超18亿美元，四季度环比增速放缓

本文来源：时代财经作者：张羽岐图片来源：图虫创意明星抗癌药CAR-T细胞疗法西达基奥仑赛注射液（英文商品名：Carvykti；中文商品名：卡卫荻）去...

01-22 22:23
U.S. RESEARCH ROUNDUP-Cencora, Crocs, Teledyne Technologies

U.S. RESEARCH ROUNDUP-Cencora, Crocs, Teledyne Technologies Jan 22 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Cencora, Crocs and Teledyne Technologies, on Thursday. HIGHLIGHTS * Cencora COR.N : Jefferies raises to b

01-22 15:17
强生今年营收有望破千亿美元：去年净利增九成，CAR-T收入增95%

跨国药企强生交出了营收净利双增的业绩，来自中国的CAR-T疗法销售表现亮眼。当地时间1月21日，美国强生公司公布2025年四季报以及全年财报。2025年第四季...

01-22 15:06
纳斯达克中国金龙指数升逾2% 热门中概股普遍拉升哔哩哔哩、百度涨超6%

金吾资讯

01-21 22:53
Legend Biotech To Present Six Poster Presentations Featuring Data On CARVYKTI At Tandem Meetings Of ASTCT And CIBMTR

Six poster presentations highlight CARVYKTI® efficacy, safety, and real-world outcomes across CARTITUDE trials and analyses, reflecting a maturing and expanding body of evidenceSOMERSET, N.J., Jan. 21, 2026 (GLOBE

01-21 21:10
Genscript Highlights Strong Q4 2025 CARVYKTI® Sales Reported by Legend Biotech

The latest announcement is out from Genscript Biotech ( ($HK:1548) ). Genscript...

01-21 21:08
Legend Reports US$555 Million CARVYKTI Sales for Q4 2025

Legend Reports US$555 Million CARVYKTI Sales for Q4 2025 GenScript Biotech Corporation announced that its associate, Legend Biotech Corporation, reported preliminary net trade sales of approximately US$555 million for CARVYKTI® for the quarter ended 31 December 2025. This update follows previous ann

01-21 20:58
美股夜盘 | 22nd Century Group, Inc.涨5.68%，嘉楠科技涨4.71%

22nd Century Group, Inc.涨5.68%；嘉楠科技涨4.71%；房多多涨4.67%

01-21 14:02

公司名稱	传奇生物
行業分類	--
業務描述	Legend Biotech Corp. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, manufacturing, and commercialization of novel therapies for oncology and other indications. The firm develops advanced cell therapies across a diverse array of technology platforms, including autologous and allogeneic chimeric antigen receptor T-cell, gamma-delta T cell and natural killer cell-based immunotherapy. It operates through the following geographical segments: United States of America, China, and Other. The company was founded in 2014 and is headquartered in Somerset, NJ.

派息除權日	每股總股息	派息日期

傳奇生物 LEGN 深 滬

18.56

個股概要

財務分析

公司資料

相關新聞

分紅派息

相關新聞

公司簡介

傳奇生物 LEGN 深滬